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Abstract
Familiaritywiththeconceptsandmethodsofhumangeneticsisimport-
ant in order to be able to perform genetic analysis.
Peter Propping
1
The grade of predictability of a genetic disease is partly given by formal
genetics but also depends on the importance of the mutated gene for
the phenotype.
1 Institute for Genetic,
University Hospital Bonn,
Germany
Possibilities for genetic analysis range from differential diagnosis to
predictive diagnosis to prenatal diagnosis. After initial consultation in
which the physician fully explains the procedure to the patient, it is
mandatory that the patient give his full consent.
Thisarticlesummarisesandevaluatescurrentknowledgeaboutgenetic
analysis of important otorhinolaryngeal diseases, including hereditary
hearingdisabilities,olfactorymalfunction,hereditarytumorousdiseases,
hereditarysyndromesanddysplasias.Inaddition,thisarticlediscusses
genetic diseases that affect voice and speech, highlights the relevance
ofhumangeneticconsultationanddiscussestheimportanceofembed-
ding genetic analysis in medicine in general.
Keywords: humangenetics,geneticdiagnosticprocedures,inheritance
of otorhinolaryngeal diseases
1 Introduction
Diagnosticproceduresinmedicallaboratorieshelprecog-
nize certain diseases through parameters, which show
measurable change due to pathophysiological mechan-
isms such as elevation of enzymes after tissue necrosis,
production of antibodies due to antigen contact or a
change in hormonal levels within a feed-back control
system.
Opposingthesepathophysiologicalphenomenons,genetic
diagnosis surveys disease aetiology. DNA sequencing is
initiated when there is suspicion of a disease caused by
geneticalteration.Therearenumerousgeneticmutations
within the human genome, as approximately every thou-
sandth base pair is variable, a prevalently genetic poly-
morphism without functional meaning. Generally, muta-
tions can range anywhere from causing severe malfunc-
tion to being functionally irrelevant. The effect a genetic
mutationhasonthephenotypedependsontheinfluence
of the mutation on the gene product, which alters its
quality.
Thus the relevance of diagnosing a genetic mutation de-
pends on its contribution to the disease. One can easily
see this looking at Mendelian inheritance. It is important
to understand that human genetics in general are based
on formal genetics as well as functionalsynopses. These
principles form the foundation of research and genetic
diagnosis and will be explained here in order to fully
understand the possibilities and limitations of genetic
research.
2 Basic principles of inheritance
2.1 Monogenetically inherited diseases
In human genetics there is a traditional differentiation
betweenautosomallydominantandrecessiveinheritance.
When carrying out genetic analysis, it is important to
realisethattherearemanyformalandfunctionalcharac-
teristics concerning diseases with simple inheritance.
Autosomally dominant inheritance
In this inheritance a phenotypical alteration is evident,
although only one allele is mutated (Figure 1). Here a
vertical transmission can be seen, which means that
there will be a phaenotypical descent between genera-
tions with a 50% chance for each child to inherit the
mutation.
If the disease-determining mutation is new in the exam-
inedpatient,thefamilyhistorywillbeinconspicuous.This
especially applies to severe diseases which often result
in non parous patients. Diseases with numerous new
mutations occur with a similar frequency in different
ethnicgroups.Thedominanteffectisaresultoffunctional
disorder, which cannot be compensated through other
organism mechanisms.The penetrance of an autosomal
dominantmutationcanbedecreased,penetranceresem-
bling the percentage of mutation carriers displaying the
phenotype. If the presence of a mutation is unclear due
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Review Article OPEN ACCESSFigure 1: The three most common hereditary transmissions. Autosomal dominant transmission indicates that the patient
displaying the characteristic feature is heterozygote for the responsible mutation. Full penetrance of the mutation leads to a
reliable diagnosis of the genotype through analysing the phaenotype.
In an autosomal recessive inheritance transmission, the patient showing the characteristic feature must have two causative
mutations,eitherhomozygoteorcompoundheterozygote.Theparentsofthepatientarephaenotypicallyinconspicuous,although
theyareheterozygote.Ifthemutationresponsibleforthediseaseislocatedonthex-chromosome,thisresultsinapredominance
for male patients. Mothers of the patient are phaenotypically inconspicuous (see text for variance). They are heterozygote and
thus carriers for the disease.
to this fact, molecular genetic examination can provide
answers.
Autosomal recessive inheritance
In an autosomal recessive inheritance both homolog
genes are mutated in a homozygote (same mutation) or
compound-heterozygote(differentmutations)way,result-
ing in a loss of function (Figure 1). The patient receives
one allele from his father and one from his mother. Both
parents,andtypicallytheirancestors,arehealthy,asthey
are heterozygote. Siblings are affected on an average of
25% (horizontal transmission). If parents are related to
eachother,autosomalrecessiveinheriteddiseasesoccur
more frequently, as the causal mutation is passed down
overasharedrelativeencounterinthepatient.Autosomal
recessive diseases occur in different ethnic groups with
varied frequency, as the causative alleles are unevenly
spread out among ethnic groups due to evolutionary
reasons. An autosomal recessive disease occurring in
two different ethnic groups can be the result of different
mutations within the same allele.
X-chromosomal recessive inheritance
The mutation responsible for the disease is located on
the x-chromosome,resultingin a predominancefor male
patients (karyotype 46,XY) suffering from the disease.
Most x-chromosomal inherited diseases are recessive,
so females (Karyotype 46,XX) are usually healthy as they
carry one unmutated gene with normal function. In this
case the normal gene can compensate for the mutated
gene. Women are carriers for the disease. The mutation
is typically passed down from the mother to 50% of her
sons. Brothers of the carrier-mother can suffer from the
disease if their mother was also a carrier.
Femalecarriersarecommonlyunaffectedphenotypically,
or at least less than male carriers of the mutation. The
reason is that one x-chromosome is functionally inactive
in all females, as it is almost completely methylated in
every cell at an early embryological stage. This prevents
transcription of the mutated gene. The process of inacti-
vation is stochastic. Female mutation carriers average
50% of the gene product in comparison with healthy
women.Insomecasestheinactivationprocesscanresult
inunevendistribution,sothatslightsymptomsofdisease
can also occur in female mutation carriers. X-chromo-
somal inherited diseasescan also occur for the first time
in a family. In this case, the disease is most likely due to
anewmutation.Thepercentageofnewmutationsamong
all patients suffering from a certain disease depends on
the severity of the disease. If the disease is so severe
that it causes the patients to remain childless (genetic
lethality), one third of the patients are the result of a new
mutation.
Mitochondrial inheritance
The largest part of human DNA is found in the cell nu-
cleus, with nuclear gene coding. Some DNA is found
within mitochondria; here DNA is annular and codes for
13transcripts.Asthesetranscriptsplayanimportantrole
within the respiratory chain, mutationsresultin malfunc-
tion of organs with a high aerobe metabolism such as
thebrain,sensoryorgansandmuscles.Mitochondriaare
passed down over the ovum, which means diseases can
only be inherited from the mother and cannot be passed
downbythefather.Everycellhasthousandsofmitochon-
dria, but not all of them carry the mutation (heteroplas-
mia),sophenotypeswithinafamilycarryingthemutation
can vary. Although it is clearly a maternal inheritance,
mutations are often difficult to diagnose due to the vari-
ance in severity of the disease.
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Monogenic diseases with a high rate of new mutations
are commonly severe. Patients remain childless in most
cases, resulting in the deletion of the mutation from the
genepool.Dominantlyinheriteddiseaseswithearlyonset
are usually not as severe as autosomal recessive dis-
eases. Autosomal recessive mutations are commonly
found in a heterozygote condition within the population.
As genetic selection of these recessive mutations can
only take place in homozygote patients, it is by far more
seldom than genetic selection of dominant genes.
Most monogenic inherited diseases are rare within the
populationastheyaregeneticexceptions.Thesediseases
are very important from a scientific and diagnostic point
of view. A good example is deafness: half of the cases of
prelingualdeafnesshaveageneticcause.Analysispoints
to a defined genetic cause, if the disease follows the
modelofinheritanceofMendel.Thesefamilieswereideal
examplesfor genetic couplinganalysisandidentification
of the responsible gene. Another example is deafness
within the context of a defined syndrome. These patients
differ qualitatively from non-syndromal patients. Identifi-
cation of genes takes place in the same manner. As the
sequence of the human genome is revealed today, one
can examine the suspicious gene if a characteristic
phenotype occurs and the location of the syndrome is
known.
2.2 Complex genetic diseases
As opposed to monogenetic determined diseases, non-
monogeneticdiseasesdisplaycertainsimilarities,butdo
not follow a specific inheritance. Examples are Diabetes
types1and2,hypertension,andpresbyacusis.Theaetio-
logical aspect of these maladies cannot be itemized
phenotypically. Most diseases with a diverse genetic
complexityhavemultiplefactorsthatprovidethefounda-
tion, implying that the patient possesses a combination
of interworking genotypes that induce the disease. How-
ever,exogenousinfluenceshavetobetakenintoaccount
as well. The disposition to suffer from a certain disease
isinheritable;itsmanifestationalsodependsonenviron-
mental influences. Diseases with a diverse genetic com-
plexityoccurmorefrequentlyamongrelativesincompari-
son with the common population. Their pattern cannot
be assigned to a dominant or recessive inheritance, due
to the fact that single components of the genetic dispos-
ition profile can be found on different chromosomes and
are therefore passed down independently. First-degree
relatives of a patient hold some but not all components
ofthedispositionprofile.Ifrelativesindependentlyreceive
single mutations leading to a disposition, they will also
be affected. Regarding the collective of patients with a
genetically complex disease, such as presbyacusis, part
of the cases will be due to exogenous influences such as
exposure to noise. From a genetic point of view this is
called phaenocopia. Some cases will actually have a
monogenetic inheritance. Looking at presbyacusis, one
gene might be mutated with a weak functional restraint,
whereasadifferentmutationwithinthesamegenemight
lead to early hearing impairment.
Aim of research regarding multifactorial
diseases
A single mutation or genotype can only explain part of
aetiologywithinamultifactordisease.Itiscrucialthough,
to have a closer look at the entire profile of mutations
congregated within one patient. At this stage it is im-
possible to determine a genetic profile for a multifactor
disease. Even if all mutations of a disposition profile are
known at some point, one is still able to state only the
probability for the actual incidence of suffering from the
disease.Here,geneticresearchsupportstheenlightment
ofthepathophysiologicalpathsofdiseases.Thissupports
development of new therapeutical targets.
3 Characteristics of genetic
diagnostics
Geneticdiagnosticdiffersfromusuallaboratorydiagnostic
inmultipleways.Everydoctorplanninggeneticdiagnostic
should be familiar with these differences.
• Mutations within one gene can have varying results,
such as base exchange (missense mutation, stop
mutation) or small deletion leading to a shift of the
sequence of reading the DNA. The mutation can also
result in the deletion or duplication of larger parts of
the DNA. It is also possible that changes without
functional consequence are detected. Sometimes it
is difficult to decide whether the mutation is compat-
ible with the phenotypical consequences. The investi-
gator has to interpret his findings in relation to the
methodsheused.Evencompletesequencingofagene
doesnotrevealallmutations,asforexample,ahetero-
zygotecellwillonlyshowthehealthygene,eventhough
the other chromosome might inherit a mutation.
• Conventionallaboratoryparametersonlyshowastate,
which can normalize during the cure of the disease,
whereas genetic analysis displays a trait, which is
definite. This has to be explained to the patient in de-
tail.
• genetic results can have an impact on relatives
• genetic diagnostic is highly differentiated, so only a
specialist having phenotypical information about the
patient can decide which gene to investigate.
• A finding analyzed in a genetic laboratory must be in-
terpreted by a consultant,who gives his opinionabout
the result in the context of an analysis.
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As in every laboratory diagnosic, a genetic diagnosic re-
quires proper indication. There are three categories of
indication:
• genetic diagnostic in course of differential diagnosic
• predictive genetic diagnostic
• prenatal genetic diagnostic
4.1 Genetic diagnostic in the context of
differential diagnosis of a disease
If a certain genetic disease seems possible because of
the clinical presentation or the family history, a targeted
genetic analysis can support this diagnosis. This is only
possible, if the presenting symptoms substantiate the
suspicion(e.g.WaardenburgSyndrome).Anonsyndromic
hearingimpairmentmakesgeneticdiagnosisverydifficult,
as there is a high grade of heterogenia.
4.2 Predictive genetic diagnostic
Some genetic diseases commence in the course of life
time, such as many types of hearing disabilities. If a pa-
tient carries a known disease-inducing mutation, as it is
known for autosomal dominant hearing impairments,
analysiscanidentifythemutationinsiblingsandchildren
of the patient in order to select the risk profile for the
disease. This is called predictive genetic diagnostic. If a
healthy relative does not carry the disease-inducing
mutation, one can conclude that this person will not de-
velop the hearing impairment caused by the mutation. If
themutationisfoundintheexaminedperson,thechance
of developing a hearing impairment depends on the
penetrance of the mutation. If the penetrance is high, up
to 100%, the predictive genetic analysis has identified a
“healthysickperson”ora“sickhealthyperson”.Thiscan
be a strain for the affected person, especially if a cure or
preventiondoesn’texist.Thisisthereasonwhyadetailed
consultationisalwaysnecessarypriortogeneticdiagnos-
tic, clarifying the consequences genetic analysis might
have. The patient must give consent to the diagnostic
procedure.
4.3 Prenatal genetic diagnostic
If a hearing impairment is passed on within a family
throughautosomaldominantinheritance,childrenofthe
patient have a 50% chance of developing the same dis-
ease. If the hearing impairment is genetically autosomal
recessive, parents are taken by surprise by the disease.
The parents are phenotypically healthy, genetically both
suffer from the mutation responsible for the hearing dis-
ability. They are heterozygote. The risk of passing the
disease down to another child represents 25%. If both
mutations are localized and analysed, it is possible to
perform prenatal genetic diagnostic. Parents seldom
make use of this possibility, though, especially regarding
autosomal dominant forms of hearing impairment, as
thesetypesarenotsevere,mostlynotfullypenetrantand
commence later in life. If a couple is planning on having
prenatal diagnostic, it is again important to clarify the
procedure carefullyin advance, especially shedding light
onthequestion,whichconsequencesapossiblemutation
might have for the course of the pregnancy.
5 Genetic diagnostic in
otorhinolaryngeal diseases
There are a great number of genetic diseases or syn-
dromes within the speciality of Otorhinolaryngeology, the
majority are hearing disabilities. In the following, import-
antexamplesofeverykindofdiseasewillbesummarised
5.1 Hereditary hearing disabilities
Hereditary hearing disabilities count among the most
common human diseases. As there is great clinical vari-
ability, diagnostic is complicated. It is also difficult to
identify the mutation causing a certain disease, due to
the fact that there is a distinct genetic heterogeneity.
The research on hereditary hearing disabilities has con-
siderably contributed to the understanding of hearing
andtothemolecularstructureoftheinnerear.Approxim-
ately one in 1000 newborns show congenital deafness,
halfofthecaseshaveageneticcause(Figure2).Inhighly
developed countries one can see a decrease of exogene
causes for deafness, so the fraction of genetic causes is
increasing. The allocation of genetic causes is also
demonstratedinFigure2.Syndromalhearingimpairments
are characterized by the fact that the hearing disability
is part of a super ordinate syndrome, as opposed to an
insulated defective hearing, which is then constituted as
non-syndromal.
5.1.1 Syndromal types of hereditary defective
hearing
There are over 400 known syndromal forms of defective
hearing [1]. Here we will illuminate some of the most
commonforms(Table1).Asyndromalhearingimpairment
occurs as the consequence of a gene mutation resulting
in the malfunction of different organs, such as the dys-
function of potassium transport in Jervell-Lange-Nielsen
Syndrome. This malfunction leads to disturbance of con-
duction in the heart and deafness.
The confirmation of the mutation in the gene typical for
thesyndromeconfirmsthesuspecteddiagnosis,whereas
a missing mutation does not necessarily exclude the ex-
istenceofthesuspectedsyndrome.Itispossiblethatthe
mutation is within a non-analysed section of the gene
(e.g. part of the intron close to an exon or promotor part).
Furthermore the mutation might be within a hitherto un-
exploredgene.Thereforeanotorhinolaryngeologistmust
always initiate a check-up of other possibly affected or-
gans when suspecting the existence of a syndrome.
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Table 1: Examples for syndromal deafness [1], [13]. SHI = sensorineural hearing impairment; CHL = conductive hearing loss.
5/10 GMS Current Topics in Otorhinolaryngology - Head and Neck Surgery 2008, Vol. 7, ISSN 1865-1011
Propping: Genetic analysis for early diagnosis of otorhinolaryngeal ...Table 2: Mitochondrial inheritance: non syndromal deafness [15], [16]
5.1.2 Non-syndromal, autosomal types of
hereditary hearing impairments
Non-syndromal forms of defective hearing are character-
izedbyanextraordinarygeneticheterogeneity.Approxim-
ately 100 genes, so far partly unexplored, are involved.
All three hereditary transmissions can be found: auto-
somal dominant, autosomal recessive and x-chromo-
somal. Over 75% of genetic early onset diseases are
autosomal recessive and commonly very severe. About
25% of the cases are autosomal dominant and become
manifestwithinearlyadulthood.Thesecoursesofdisease
can be progressive or non-progressive. Hearing impair-
ment can be limited to certain frequencies. 1–2% of
genetic early onset diseases are x-chromosomally in-
herited. As there is again broad genetic heterogeneity, it
can be difficult to identify the mutation. If there is no
evidenceforasyndromaltypeofdisease,itmakessense
to examine the gene coding for connexin-26 (GJP2), as
it is a small gene and commonly affected in autosomal
recessivediseasetypes.15–20%ofautosomalrecessive
forms of defective hearing in Germany are due to a
mutation of GJP-2. In Mediterranean areas, a certain
mutation in the GJP-2 gene (30delG) occurs strikingly
often,thefrequencyofheterozygotebeing1:31[2].From
thisonecanconcludethefrequencyofhomozygote,which
is 1:3800.
Even if the GJP-2 gene carries a homozygote mutation,
the grade of hearing impairment can differ. Presumably
thereareothergenesaffectingthedefectofGJP2-protein
with their gene product. There are also rare autosomal
dominant mutations within this gene.
If no mutation is found in GJP-2, so far no alternative
routine method exists to find a mutation in a different
gene causing the disease. Consulting large laboratories,
which can scan multiple other genes for mutations re-
mains a possibility.
Whatreasonsarethereforperformingmutationanalysis?
If parents conceive a child with congenital deafness
without a determined cause and with an inconspicuous
familyhistory,anautosomalrecessiveinheritanceisvery
likely.Findingamutationinthedeafchildmakespredict-
ivediagnosticinnewbornsiblingspossible.Thisenables
the parents to begin adequate therapy right away, if the
sibling has the same genotype as the patient. If the dis-
ease inducing genotype is excluded in the sibling, no
further diagnosic procedures concerning hearing ability
are necessary. This applies to other hereditary transmis-
sions including the mitochondrial pathway. Genetic
diagnostic can also have a therapeutic impact, as it can
be used for early diagnosis of hereditary hearing impair-
ments. Discovering the responsible genetic modification
is only successful in a small number of cases. One can
expectaprogressionofdiagnosticproceduresinthenext
years, for example kits enabling sequencing for all genes
with possible mutations responsible for hearing disabil-
ities.
5.1.3 Mitochondrially coded defective hearing
There are 2 genes in the mitochondrial DNA that lead to
amonogenhereditaryhearingimpairmentwhenmutated
(Table 2). In the majority of cases the development of a
sensorineural hearing impairment occurs in early adult-
hood. However, there are also many mild courses of dis-
ease,manyofwhichmightbeduetoheteroplasmia.Here,
a clinical diagnosis is not easy. The penetrance amounts
to 80% at 65 years.
Mutations of the MT-RN1-gene are closely related to
aminoglycosideantibiotics,resultinginpossibledeafness
after just a single dosis of gentamicin, tobramycin, ami-
kacin, kanamycin or streptomycin. It is important for the
ENTdoctortoidentifytheriskprofile.Ifthereissuspicion
of a maternal inheritance of a hearing impairment, con-
sultation with a professional for human genetics should
be initiated, so that mitochondrial coded genes can be
analyzed. This indication should be made generously. A
MT-RNR1 gene carrier should never undergo
aminoglycosidetherapy.Atriskpatientscanbeidentified,
as it is characteristically a maternal inheritance. These
patientsshouldundergogeneticconsultation,givingthem
insight into possible molecular genetic analysis.
5.1.4 Otosclerosis
Up to 1% of the European population are affected by
otosclerosis. A high familiarity has been known for a long
time. In spite of intensive research on this disease, so
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which would be useful for diagnostic purposes.
5.2 Hereditary malfunction of the
olfactory sense – Kallmann Syndrome
TheKallmannsyndromeischaracterizedbyacombination
of anosmia and hypogonadotrophic hypogonadism. Af-
fected men do not develop secondary sexual character-
istics, affected women do not develop breastsand suffer
from amenorrhoea. In addition, kidney agenesia, cheilo-
gnathopalatoschisis, brachy- and/or syndactylia or
agenesia of the corpus callosum can occur. Clinical
presentationofthesyndromeissupplementedbydiagno-
sisoflaboratoryparameterssuchasdecreasedhormonal
levels(LH,FSHandsexualhormones)andaninconspicu-
ous MRI result of the pituitary gland. The diagnosis is
oftentheresultofthephysicalexaminationpriortojoining
the army. The differential diagnosis between Kallmann
syndrome and Klinefelt syndrom can be made through
an olfactory test. Patients with Klinefelt syndrome have
intact olfactory senses. Additionally, they suffer from hy-
pergonadotrophic hypogonadism. Kallmann syndrome
can be caused by mutations in 4 different genes: KS1
throughKAL1onthex-chromosome,KS2throughFGFR1,
KS3 through PROKR2, KS4 through PROK2. Whereas
KS1 is passed down on the x-chromosome, KS2-4 is in-
herited in an autosomal dominant transmission. So far
proof of mutation is only successful in about 25% of the
cases, even when patients present typical clinical fea-
tures. This is probably due to more unidentified genes
responsible for the disease. If Kallmann syndrome is
suggested, the ENT doctor should transfer the patient to
a geneticist. Other family members are potential carriers
of the Kallmann mutation. Hormones should be substi-
tuted. With an adequate endocrinological therapy, pa-
tients can even reach the state of fertility.
5.3 Tumour diseases
Tumourdiseases,especiallymalignantdiseases,depend
on genetic state at the cellular level. A cascade of muta-
tions surrounding genes controlling the cell cycle must
occur in order to provoke uncontrolled tissue growth.
Mosttumourdiseasesaredueto somaticmutationsand
do not have a hereditary genetic cause. Some tumour
diseases are hereditary, mostly due to mutations in the
germlineresultinginmutationsineverycelloftheembryo.
This is a constitutional genetic change. In consequence,
hereditary tumour diseases are mutations of tumour
suppressor genes, proto-onkogenes or repair genes. The
manifestation in organs depends on the tissue-specific
expression and cell division activity.
5.3.1 Neurofibromatosis type 2
Neurofibromatosis type 2 (NF2) is characterized by bilat-
eral vestibular schwannoma causing tinnitus, defect of
hearing and vertigo [3]. The diseases are passed down
in an autosomal dominant hereditary transmission. The
approximate age of manifestation is 18–24 years; late
onsetupintothe70sisalsopossible.Schwannomascan
alsooccurinotherbrainstemnerves.Furthermore,other
tumour entities such as ependymomas, astrozytomas
andmeningeomascanbefound.Aposteriorsubcapsular
opacity of the lense is an important clinical feature for
diagnosingNF2,althoughthisnormallydoesnotinfluence
seeing ability. The clinical diagnosis of NF2 should con-
sider family history. NF2 is due to a mutation in a tumour
suppressor gene, severity of the disease depends on the
type of mutation [4]. The mutation rate can be as high as
50%. As it is a matter of an autosomal inheriditary trans-
mission, the risk of passing down the gene is 50%. Once
amutationisidentified,predictivegeneticdiagnosticcan
be performed on relatives (Figure 3). Timely detection of
mutations allows patients to begin treatment earlier. Pa-
tientswithamutationandpatientswithahighriskprofile
should have an MRI annually from the age of 12. These
patients should undergo a human genetic consultation
prior to predictive diagnostic, when the diagnosis of NF2
is suspected.
5.3.2 Paragangliomas
Paragangliomas are a rare familial appearing tumour
entity with an autosomal dominant hereditary transmis-
sion. These tumours develop in the neck area and are
sometimescombinedwithextraadrenalphaeochromozyto-
mas, papillar thyroid gland carcinomas and kidney cell
carcinomas[5].Therearetwocommongenes,whichcan
be mutated (SDHB, SDHD). Aberrant from autosomal
dominant inheritage transmission, these tumours are
exclusively passed down through paternal germ cells.
Here, genomic imprinting takes place, meaning that the
mutatedgeneisinactivatedduringoogenesis[6].Patients
withasuspectedfamilialparagangliomaandtheirfamilies
should submit to human genetic consultation. The diag-
nostic situation is difficult; predictive genetic diagnostic
is possible.
5.4 Congenital syndromes and
dysplasias
Organs of the head and neck develop in a complicated
ontogenesis,controlledthroughalargenumberofgenes.
The existence of many congenital dysplasias is therefore
not surprising. As genes often play important regulatory
roles in multiple organic systems, organs can have a
congenital malfunction simultaneously. Because this is
typical for genetic syndromes, a child with a dysplasia
should be scanned carefully for other malformations. As
highlyspecializedmedicinenowpermits,thisruleshould
be carefully followed.
Geneticnosologydividesdiseasesintogeneticcategories,
so the human geneticist is accustomed to thinking in
termsof the organismandnot merelythe organandalso
regards the patient’s family and not just the patient. In
the following we will present examples of syndromes and
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identified within the family, predictive genetic diagnostic is possible. Underneath the symbols of the person, the genotype is
displayed. Family members II:4, III:1 and III:2 are healthy mutation carriers. These patients will definitely develop the disease.
dysplasiasoftheheadandnecksection.Mostcongenital
dysplasias are not specified or even fully understood
genetically. Partly, this is due to the fact that these dis-
easesare very rare. Progresscan only be made, when all
medical disciplines work together.
5.4.1 CHARGE Syndrome
CHARGE stands for coloboma, heart defect, choanal at-
resia, retarded growth and development, genital abnor-
malities and ear abnormalities [7]. Among these symp-
toms, choanal atresia, dysplasia of the ear conch, hyp-
or anosmiasensorineural sensorineural or conduction
hearing loss, oro-facial clefts and tracheo-esophageal
fistulas are within the head and neck specialisation; this
can be determined through clinical presemntation or
throughdiagnosis.Ifthereissuspicion,moleculargenetic
examination is possible. CDH7 is the gene known to
mutate in about 65% of the cases. The largest amount
ofcasesisduetoadominantnewmutation.Thedisease
can be severe in childhood. If the disease is autosomally
dominant, it is not as severe and patients can reach
adulthood. The grade of dysplasia can vary, even within
one family presenting the same mutation.
5.4.2 Franceschetti Syndrome (Dysostosis
mandibulfacialis, Treacher-Collins Syndrome)
Franceschetti syndrome is characterized by a hypoplasia
of the zygomatic bone and mandibula, by a koloboma
and the absence of cilia of the lower palpebra and dys-
plasia of the ear concha [8]. Half of all patients suffer
from a conduction hearing loss due to a dysplasia of the
middle ear ossicula. Cheilognathopalatoschisis and cho-
anal atresia can also occur. In representative cases the
diagnosis is clinical. The syndrome is passed down in an
autosomal dominant transmission, 60% of the cases
being due to new mutations. Carriers of the mutation
pass the disease to 50% of their children. The genetic
cause is a mutation of the TCOF1-gene. A mutation is
determined in over 90% of cases.
5.4.3 Holoprosenzephalia
Holoprosenzephalia (HPE) is a structural abnormality of
the brain. The prosenzephalon is not split into two hemi-
spheres. The syndrome can show different stages of
severity beginning with lobular forms over semilobular
uptoalobularholoprosenzephalia.Mostpatientspresent
with severe ideokinetic retardation, severely affected
children die within their first year. Most often patients
present with variable kraniofacial dysplasias, such as
absence of or a very flat nose, only one nostril, absence
of the ossa nasa, defects around the middle in the
palatinal bone, uvula bifida, absence of the frenulum of
the upper lip or with only a single incisor [9]. Holoprosen-
zephalia can be part of a chromosomal dysplasia syn-
drome. It can occur due to dominant new mutations or
can also be dominantlyinheritable in mild cases. To date
there are four identified genes (TGIF, SIX3 and ZIC2),
8/10 GMS Current Topics in Otorhinolaryngology - Head and Neck Surgery 2008, Vol. 7, ISSN 1865-1011
Propping: Genetic analysis for early diagnosis of otorhinolaryngeal ...whose mutationcan lead to holoprosenzephalia.In addi-
tion to mutations, microdeletions can also lead to the
disease. The risk of recurrence for children or their rela-
tives is dependent on the cause. Molecular diagnostic is
difficult and should remain in experts’ hands.
5.4.4 Branchio oto renal (BOR) Syndrome
The BOR syndrome is characterized by dysplasia of the
external-, middle-, and internal ear resulting in both con-
ductionhearinglossandsensorineuralhearingloss[10].
Furthermore fistulas and cysts of the pharyngeal arches
and dysplasias of the kidneys can be symptoms of the
syndrome. The severity of the syndrome varies even
within a family. Again, diagnosis is clinical. It is a matter
of an autosomal dominant inheritance.A mutation in the
EYA1- gene is detectable in 40% of the cases. Few pa-
tientshaveamutationintheSIX1-gene.Presumablythere
are other genes, which have not yet been identified.
5.5 Diseases of the voice and speech
Genetic factors most probably play a role in the develop-
ment of diseases of the voice and speech, as family and
twin analysis suggest. It is most likely that genes con-
trolling the nervous system are the most relevant. It is
one of the most fascinating research challenges to fully
discover and understand genetic mechanisms and the
plasticity of their impact. Our knowledge of these mech-
anisms is still only fragmentary, so that any practical
usage of genetic diagnostics regarding diseases of the
voice and speech is not possible.
6 Human genetic consultation –
embedding genetic diagnostics in
medicine in general
Declaration of a genetic cause for a dysfunction or dis-
ease can be very incriminating for the patient as it can
resultinstigmatization.Whenapatient’sdiseaseisgiven
a genetic cause, it can often result in the feeling that a
judgmenthasbeenpassed,especiallyifthereisnosuffi-
cient therapy or if the symptoms are clearly externally
visible as in many genetic syndromes. It is the duty of
every doctor to carefully introduce the patient to all
technicaltermsandtoexplainallbiologicalmechanisms,
giving the patient the chance to fully understand the
problem and in so doing providing assistance for living
with the syndrome. Genetic analysis should only be per-
formed if the patient gives his full consent and after
clarifyingallimportantfactswiththephysician.Predictive
geneticdiagnosticisnoteworthy,asitgenerates“healthy
sick” or “sick healthy” patients. The guidelines of the
Germanmedicalassociationdictatethatgeneticdiagnos-
ticscanonlybeperformedafterhumangeneticconsulta-
tionandpatientconsent.Geneticconceptsandmethods
are becoming more and more important in medicine. An
interdisciplinary dialogue between doctors of different
specialities with the geneticist is mandatory to account
for the well-being of each patient and his family.
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